These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24131838)

  • 1. [Impact factors for efficacy of specific immunotherapy in children with dust mite allergic asthma].
    Liu J; Zhang XB; Feng HY; Huang JF; Zhang MZ; Wang LB
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):854-9. PubMed ID: 24131838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
    Zhang X; Li MR; Wang C; Wang XN; Zhang HL; Lin J; Jin K; Li YC
    Zhonghua Er Ke Za Zhi; 2010 Jul; 48(7):526-30. PubMed ID: 21055090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of specific immunotherapy on house dust mite-induced allergic rhinitis in China.
    Peng H; Li CW; Lin ZB; Li TY
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):40-6. PubMed ID: 23569202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for clinical response to allergy immunotherapy in children with asthma and rhinitis.
    Li Q; Li M; Yue W; Zhou J; Li R; Lin J; Li Y
    Int Arch Allergy Immunol; 2014; 164(3):210-7. PubMed ID: 25138246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic efficacy of 3-year subcutaneous immunotherapy in asthmatic children allergic to mite].
    Li L; Hui Y; Qian J; Guo Y; Zhang XL; Zhang XJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 May; 15(5):368-71. PubMed ID: 23676940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
    Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
    Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-specific IgE and allergen immunotherapy in allergic children.
    Tosca M; Silvestri M; Accogli A; Rossi GA; Ciprandi G
    Immunotherapy; 2014; 6(1):29-33. PubMed ID: 24341881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific IgG4 production during house dust mite immunotherapy among age, gender and allergic disease populations.
    Lai X; Li J; Xiao X; Liu E; Zhang C; Wang H; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2013; 160(1):37-46. PubMed ID: 22948109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of sublingual immunotherapy in children with dust mite allergic asthma].
    Ma XP; Muzhapaer D
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):344-7. PubMed ID: 20497640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite.
    Inal A; Altintas DU; Yilmaz M; Karakoc GB; Kendirli SG; Sertdemir Y
    J Investig Allergol Clin Immunol; 2007; 17(2):85-91. PubMed ID: 17460946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
    Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
    Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
    Marogna M; Spadolini I; Massolo A
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.
    Rosewich M; Arendt S; El Moussaoui S; Schulze J; Schubert R; Zielen S
    Pediatr Allergy Immunol; 2013 Aug; 24(5):434-40. PubMed ID: 23578317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children.
    Cevit O; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    J Investig Allergol Clin Immunol; 2007; 17(5):286-91. PubMed ID: 17982919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children.
    Ajduk J; Marinic I; Aberle N; Rabatic S; Gagro A
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):314-22. PubMed ID: 18450115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.